✦ LIBER ✦

Abstracts: International workshop on effects of low doses of endocrine active compounds

Book ID: 116450501
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 322 KB
Volume: 98
Category: Article
ISSN: 0013-9351
DOI: 10.1016/j.envres.2004.06.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

International Workshop on Effects of Low

International Workshop on Effects of Low Doses of Endocrine Active Compounds: Berlin, Germany, November 20–22, 2003

✍ Ibrahim Chahoud; Konstanze Grote; Chris E. Talsness; Martin Paul 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Effect of low-dose oral contraceptives o

Effect of low-dose oral contraceptives on natural killer cell activity

✍ David A. Baker; William Salvatore; Peter O. Milch 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 314 KB

ChemInform Abstract: Effects of a Benzim

ChemInform Abstract: Effects of a Benzimidazole Compound on Monooxygenase Activities.

✍ Z. ATES; S. SUZEN; E. BUEYUEKBINGOEL; B. CAN-EKE; M. ISCAN 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 28 KB

Effect of Low-Dose Positive Inotropic Dr

Effect of Low-Dose Positive Inotropic Drugs on Human Internal Mammary Artery Flow

✍ Jean-Luc Cracowski MD; Olivier Chavanon MD; Michel Durand MD; Elisabeth Borrel M 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 307 KB

Low-Dose Effect of Ethanol on Locomotor

Low-Dose Effect of Ethanol on Locomotor Activity Induced by Activation of the Mesolimbic System

✍ Grace V. Milton; Patrick K. Randall; Carlton K. Erickson 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 915 KB

Effect of low-dose cyclosporin a on syst

Effect of low-dose cyclosporin a on systemic lupus erythematosus disease activity

✍ Michiaki Tokuda; Noriyuki Kurata; Akihito Mizoguchi; Masayuki Inoh; Kunio Seto; 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 709 KB

Objective. To determine the effect of low-dose cyclosporin A (CSA) treatment on disease activity in systemic lupus erythematosus (SLE). Methods. All patients in the study had active disease as defined by at least the presence of a low CH50 level. Patients were initially given 3 mg/kg/day of CSA. Do